{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:20:15Z","timestamp":1766391615847,"version":"3.37.3"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"21","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100004435","name":"University of Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004435","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European FEDER","award":["PI09\/02639","PI12\/02785","PI15\/01951","PI16\/00668"],"award-info":[{"award-number":["PI09\/02639","PI12\/02785","PI15\/01951","PI16\/00668"]}]},{"DOI":"10.13039\/100008061","name":"Fundaci\u00f3n Mutua Madrile\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1093\/hmg\/ddy283","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T11:16:45Z","timestamp":1532949405000},"page":"3688-3696","source":"Crossref","is-referenced-by-count":18,"title":["Bioengineered PBGD variant improves the therapeutic index of gene therapy vectors for acute intermittent porphyria"],"prefix":"10.1093","volume":"27","author":[{"given":"Irantzu","family":"Serrano-Mendioroz","sequence":"first","affiliation":[{"name":"Hepatology Program, CIMA-University of Navarra, Spain"},{"name":"Navarra Institute for Health Research (IDISNA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Sampedro","sequence":"additional","affiliation":[{"name":"Hepatology Program, CIMA-University of Navarra, Spain"},{"name":"Navarra Institute for Health Research (IDISNA), Pamplona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naroa","family":"Serna","sequence":"additional","affiliation":[{"name":"Institut de Biotecnologia i de Biomedicina, Universitat Aut\u00f2noma de Barcelona, Cerdanyola del Vall\u00e8s 08193 Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Enr\u00edquez","family":"de Salamanca","sequence":"additional","affiliation":[{"name":"Research Center, Hospital Universitario 12 de Octubre, UCM, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantza","family":"Sanz-Parra","sequence":"additional","affiliation":[{"name":"Protein Stability and Inherited Disease Laboratory, CIC bioGUNE, Derio, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Corrales","sequence":"additional","affiliation":[{"name":"Proteomics Unit, Centro Nacional de Biotecnolog\u00eda (CSIC), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Berraondo","sequence":"additional","affiliation":[{"name":"Navarra Institute for Health Research (IDISNA), Pamplona, Spain"},{"name":"Program of Immunology and Immunotherapy, CIMA-University of Navarra, Pamplona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC), Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar","family":"Millet","sequence":"additional","affiliation":[{"name":"Protein Stability and Inherited Disease Laboratory, CIC bioGUNE, Derio, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Fontanellas","sequence":"additional","affiliation":[{"name":"Hepatology Program, CIMA-University of Navarra, Spain"},{"name":"Navarra Institute for Health Research (IDISNA), Pamplona, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"key\n\t\t\t\t20181022075331847_ref1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.7326\/0003-4819-142-6-200503150-00010","article-title":"Recommendations for the diagnosis and treatment of the acute porphyrias","volume":"142","author":"Anderson","year":"2005","journal-title":"Ann. Intern. Med."},{"key":"key\n\t\t\t\t20181022075331847_ref2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(05)70154-9","article-title":"Porphyrias","volume":"365","author":"Kauppinen","year":"2005","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20181022075331847_ref3","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10545-012-9544-4","article-title":"The incidence of inherited porphyrias in Europe","volume":"36","author":"Elder","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"key\n\t\t\t\t20181022075331847_ref4","article-title":"Acute Intermittent Porphyria","volume-title":"GeneReviews\u00ae","author":"Whatley","year":"1993"},{"key":"key\n\t\t\t\t20181022075331847_ref5","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1017\/erm.2016.18","article-title":"Emerging therapies for acute intermittent porphyria","volume":"18","author":"Fontanellas","year":"2016","journal-title":"Expert Rev. Mol. Med."},{"key":"key\n\t\t\t\t20181022075331847_ref6","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1089\/hum.2013.166","article-title":"Safety and liver transduction efficacy of rAAV5-cohPBGD in nonhuman primates: a potential therapy for acute intermittent porphyria","volume":"24","author":"Paneda","year":"2013","journal-title":"Hum, Gene Ther."},{"key":"key\n\t\t\t\t20181022075331847_ref7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jhep.2009.09.003","article-title":"Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyria","volume":"52","author":"Unzu","year":"2010","journal-title":"J. Hepatol."},{"key":"key\n\t\t\t\t20181022075331847_ref8","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1479-5876-10-122","article-title":"Transient and intensive pharmacological immunosuppression fails to improve AAV-based liver gene transfer in non-human primates","volume":"10","author":"Unzu","year":"2012","journal-title":"J. Transl. Med."},{"key":"key\n\t\t\t\t20181022075331847_ref9","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/gt.2015.64","article-title":"Helper-dependent adenovirus achieve more efficient and persistent liver transgene expression in non-human primates under immunosuppression","volume":"22","author":"Unzu","year":"2015","journal-title":"Gene Ther."},{"key":"key\n\t\t\t\t20181022075331847_ref10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/hmg\/ddx067","article-title":"Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition","volume":"26","author":"Blouin","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20181022075331847_ref11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/mt.2010.210","article-title":"Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice","volume":"19","author":"Unzu","year":"2011","journal-title":"Mol. Ther. J. Amer. Soc. Gene Ther."},{"key":"key\n\t\t\t\t20181022075331847_ref12","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jhep.2016.05.012","article-title":"Phase I open label liver-directed gene therapy clinical trial for acute intermittent porphyria","volume":"65","author":"D'Avola","year":"2016","journal-title":"J. Hepatol."},{"key":"key\n\t\t\t\t20181022075331847_ref13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1073\/pnas.85.1.6","article-title":"Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression","volume":"85","author":"Chretien","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"key\n\t\t\t\t20181022075331847_ref14","first-page":"55","article-title":"Erythroid specific promoter of an housekeeping gene","volume":"251","author":"Romeo","year":"1987","journal-title":"Prog. Clin. Biol. Res."},{"key":"key\n\t\t\t\t20181022075331847_ref15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.27086","article-title":"Liver transplantation in the management of porphyria","volume":"60","author":"Singal","year":"2014","journal-title":"Hepatol. (Baltimore, Md.)"},{"key":"key\n\t\t\t\t20181022075331847_ref16","doi-asserted-by":"crossref","first-page":"571","DOI":"10.7326\/0003-4819-154-8-201104190-00015","article-title":"Liver transplantation from donors with acute intermittent porphyria","volume":"154","author":"Dowman","year":"2011","journal-title":"Ann. Intern. Med."},{"key":"key\n\t\t\t\t20181022075331847_ref17","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/hmg\/ddt148","article-title":"Helper-dependent adenoviral liver gene therapy protects against induced attacks and corrects protein folding stress in acute intermittent porphyria mice","volume":"22","author":"Unzu","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20181022075331847_ref18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/mt.2009.250","article-title":"AAV8-mediated gene therapy prevents induced biochemical attacks of acute intermittent porphyria and improves neuromotor function","volume":"18","author":"Yasuda","year":"2010","journal-title":"Mol. Ther. J. Amer. Soc. Gene Ther."},{"key":"key\n\t\t\t\t20181022075331847_ref19","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/pro.405","article-title":"Structure and function of enzymes in heme biosynthesis","volume":"19","author":"Layer","year":"2010","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"key\n\t\t\t\t20181022075331847_ref20","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/BSR20130045","article-title":"Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria","volume":"33","author":"Bustad","year":"2013","journal-title":"Biosci. Rep."},{"key":"key\n\t\t\t\t20181022075331847_ref21","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1096\/fj.08-115469","article-title":"Structural insight into acute intermittent porphyria","volume":"23","author":"Song","year":"2009","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20181022075331847_ref22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/bi801731q","article-title":"Uroporphyrinogen III synthase mutations related to congenital erythropoietic porphyria identify a key helix for protein stability","volume":"48","author":"Fortian","year":"2009","journal-title":"Biochemistry"},{"issue":"33\u201338","key":"key\n\t\t\t\t20181022075331847_ref23","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"Journal of Mol. Graph."},{"key":"key\n\t\t\t\t20181022075331847_ref24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"key\n\t\t\t\t20181022075331847_ref25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng0296-195","article-title":"Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria","volume":"12","author":"Lindberg","year":"1996","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20181022075331847_ref26","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0021-9258(19)85981-1","article-title":"Purification and properties of uroporphyrinogen I synthase from human erythrocytes. Identification of stable enzyme-substrate intermediates","volume":"255","author":"Anderson","year":"1980","journal-title":"J. Biol. Chem."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/27\/21\/3688\/26127180\/ddy283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T12:02:19Z","timestamp":1661688139000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article\/27\/21\/3688\/5063569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":26,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2018,8,1]]},"published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddy283","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"type":"print","value":"0964-6906"},{"type":"electronic","value":"1460-2083"}],"subject":[],"published-other":{"date-parts":[[2018,11,1]]},"published":{"date-parts":[[2018,8,1]]}}}